These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30581063)

  • 1. Bicarbonate Supplement Restores Urinary Klotho Excretion in Chronic Kidney Disease: A Pilot Study.
    Hage V; Villain C; Pelletier S; Laville M; Drai J; Fouque D
    J Ren Nutr; 2019 Jul; 29(4):285-288. PubMed ID: 30581063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V; Pelletier S; Dubourg L; Drai J; Cuerq C; Lemoine S; Hadj-Aissa A; Laville M; Fouque D
    J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
    Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY; de Roij van Zuijdewijn CLM; Hoenderop JG; de Borst MH; Ter Wee PM; Heijboer AC; Vervloet MG;
    BMC Nephrol; 2018 Nov; 19(1):327. PubMed ID: 30442108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
    Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
    BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial.
    Raphael KL; Katz R; Larive B; Kendrick C; Isakova T; Sprague S; Wolf M; Raj DS; Fried LF; Gassman J; Hoofnagle A; Cheung AK; Ix JH
    J Am Soc Nephrol; 2024 Jan; 35(1):57-65. PubMed ID: 38170601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
    Akimoto T; Yoshizawa H; Watanabe Y; Numata A; Yamazaki T; Takeshima E; Iwazu K; Komada T; Otani N; Morishita Y; Ito C; Shiizaki K; Ando Y; Muto S; Kuro-o M; Kusano E
    BMC Nephrol; 2012 Nov; 13():155. PubMed ID: 23176706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial.
    Bovée DM; Roksnoer LCW; van Kooten C; Rotmans JI; Vogt L; de Borst MH; Zietse R; Danser AHJ; Hoorn EJ
    J Nephrol; 2021 Oct; 34(5):1737-1745. PubMed ID: 33382448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients.
    Szczecińska K; Wajdlich M; Nowicka M; Nowicki M; Kurnatowska I
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral sodium bicarbonate in patients with CKD.
    Abramowitz MK; Melamed ML; Bauer C; Raff AC; Hostetter TH
    Clin J Am Soc Nephrol; 2013 May; 8(5):714-20. PubMed ID: 23393105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
    Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
    BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Klotho Excretion: A Key Regulator of Sodium Homeostasis in Chronic Kidney Disease Stage 2-4.
    Chi PJ; Lee CJ; Hung SY; Tsai JP; Liou HH
    Med Sci Monit Basic Res; 2023 Nov; 29():e942097. PubMed ID: 37987256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Urine Ammonium and Urine TGF-
    Raphael KL; Gilligan S; Hostetter TH; Greene T; Beddhu S
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):223-230. PubMed ID: 29146699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
    Raphael KL; Isakova T; Ix JH; Raj DS; Wolf M; Fried LF; Gassman JJ; Kendrick C; Larive B; Flessner MF; Mendley SR; Hostetter TH; Block GA; Li P; Middleton JP; Sprague SM; Wesson DE; Cheung AK
    J Am Soc Nephrol; 2020 Jan; 31(1):161-174. PubMed ID: 31848294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.